logo

For the Inventor, By the Inventor

Milwaukee, WI, United States of America

Mcw Research Foundation, Inc.


USPTO Granted Patents = 61



Forward Citations = 906

Loading Chart...
Loading Chart...

102 inventors (with patents filed for the assignee):

goldMedal James Stewart Hyde (10 out of 24 patents)

silverMedal Andrzej Jesmanowicz (8 out of 12 patents)

bronzeMedal Richard J Roman (6 out of 9 patents)

4.  John L Ulmer (4 out of 4 patents)

5.  David R Harder (4 out of 6 patents)

6.  Wojciech Froncisz (4 out of 12 patents)

7.  Ching-San Lai (4 out of 30 patents)

8.  Balaraman Kalyanaraman (3 out of 15 patents)

9.  Dara W Frank (3 out of 5 patents)

10.  Joseph T Barbieri (3 out of 9 patents)

11.  Edgar A DeYoe (3 out of 3 patents)

12.  Kathleen M Schmainda (3 out of 4 patents)

13.  Magdalena Alonso-Galicia (3 out of 3 patents)

14.  Elizabeth R Jacobs (3 out of 3 patents)

15.  John Russell Falck (3 out of 34 patents)


Core Competencies:
Thrombopoietin Receptor Ligand
Magnetic Resonance Imaging
Drug Addiction Treatment
Cell Adhesion Properties
Cerebral Vascular Disease
Neurovascular Uncoupling
Photobiomodulation Treatment
Tumor Angiogenesis
Natural Killer Cells
Vision Disorders
Nucleotide Pyrophosphohydrolase
Immunosuppressive Agents

61 patents:

1. 8518883 - Method of reducing deleterious effects of ischemia by administration of a thrombopoietin receptor ligand (2013-08-27),
2. 8404640 - Method of diagnosing and treating colon cancer (2013-03-26),
3. 8388936 - In vivo mitochondrial labeling using positively-charged nitroxide enhanced and gadolinium chelate enhanced magnetic resonance imaging (2013-03-05),
4. 8101347 - [object Object] (2012-01-24),
5. 8021892 - System and method for direct digitization of NMR signals (2011-09-20),
6. 7943631 - Method of treating drug addiction using dextro-morphine (2011-05-17),
7. 7939326 - Methods and compositions for enhancing cell adhesion properties (2011-05-10),
8. 7879318 - Method of reducing the effects of ischemia by administration of a thrombopoietin receptor ligand (2011-02-01),
9. 7867496 - Use of TGF-β antagonists to limit nephrotoxicity of immunosuppressive agents (2011-01-11),
10. 7838561 - Method for preventing or treating cardiac hypertrophy (2010-11-23),
11. 7807474 - System and method for direct digitization of NMR signals (2010-10-05),
12. 7788075 - System and method for sensory defect simulation (2010-08-31),
13. 7603240 - Peptide identification (2009-10-13),
14. 7577472 - MRI method for producing an index indicative of brain disorders (2009-08-18),
15. 7567832 - MRI method for measuring tumor hemodynamic parameters in the presence of contrast agent extravasation (2009-07-28),
MCW Research Foundation, Inc. is a non-profit organization dedicated to advancing scientific research and medical innovation. Our mission is to support and fund groundbreaking projects that improve human health and quality of life. We collaborate with leading institutions and researchers worldwide to address pressing health challenges, such as cancer, cardiovascular diseases, neurosciences, and precision medicine. By bridging the gap between academia and industry, we strive to accelerate the translation of scientific discoveries into practical solutions that benefit patients and society as a whole.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

61 Patents

#32 in Milwaukee, WI

#145 in Wisconsin

#5,706 in US

#11,502 in the World

...
Milwaukee, WI, United States of America

Mcw Research Foundation, Inc.

Forward Citations = 906

102 inventors:

goldMedal James Stewart Hyde (10 out of 24 patents)

silverMedal Andrzej Jesmanowicz (8 out of 12 patents)

bronzeMedal Richard J Roman (6 out of 9 patents)

4.  John L Ulmer (4 out of 4 patents)

5.  David R Harder (4 out of 6 patents)

Please report any incorrect information to support@idiyas.com
Loading…